Evolving target: A 16-year progressive framework for shifting the rubric of scientific publishing toward transparency, artificial intelligence, and the Economic Impact Factor for impact that matters

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 12

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Stem Cells

ISSN

1948-0210

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Stem Cells. Dec 26, 2025; 17(12): 111748
Published online Dec 26, 2025. doi: 10.4252/wjsc.v17.i12.111748

Table 3 Top 5 most-impactful clinical trials

No.	Citation information of articles	Number of years published	Citations in RCA
1	Tsang KS, Ng CPS, Zhu XL, Wong GKC, Lu G, Ahuja AT, Wong KSL, Ng HK, Poon WS. Phase I/II randomized controlled trial of autologous bone marrow-derived mesenchymal stem cell therapy for chronic stroke. World J Stem Cells 2017; 9: 133-143 [PMID: 28928910 DOI: 10.4252/wjsc.v9.i8.133]	6	27
2	Plesa A, Dumontet C, Mattei E, Tagoug I, Hayette S, Sujobert P, Tigaud I, Pages MP, Chelghoum Y, Baracco F, Labussierre H, Ducastelle S, Paubelle E, Nicolini FE, Elhamri M, Campos L, Plesa C, Morisset S, Salles G, Bertrand Y, Michallet M, Thomas X. High frequency of CD34+CD38-/Low immature leukemia cells is correlated with unfavorable prognosis in acute myeloid leukemia. World J Stem Cells 2017; 9: 227-234 [PMID: 29321824 DOI: 10.4252/wjsc.v9.i12.227]	6	20
3	Santiago-Torres JE, Lovasz R, Bertone AL. Fetal vs adult mesenchymal stem cells achieve greater gene expression, but less osteoinduction. World J Stem Cells 2015; 7: 223-234 [PMID: 25621122 DOI: 10.4252/wjsc.v7.i1.223]	8	9
4	Shroff G. Therapeutic potential of human embryonic stem cells in type 2 diabetes mellitus. World J Stem Cells 2016; 8: 223-230 [PMID: 27468331 DOI: 10.4252/wjsc.v8.i7.223]	7	9
5	Dahabreh Z, Panteli M, Pountos I, Howard M, Campbell P, Giannoudis PV. Ability of bone graft substitutes to support the osteoprogenitor cells: An in-vitro study. World J Stem Cells 2014; 6: 497-504 [PMID: 25258672 DOI: 10.4252/wjsc.v6.i4.497]	9	6

RCA: Reference Citation Analysis.

Citation: Li SC. Evolving target: A 16-year progressive framework for shifting the rubric of scientific publishing toward transparency, artificial intelligence, and the Economic Impact Factor for impact that matters. World J Stem Cells 2025; 17(12): 111748
URL: https://www.wjgnet.com/1948-0210/full/v17/i12/111748.htm
DOI: https://dx.doi.org/10.4252/wjsc.v17.i12.111748